Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

TAIPEI, May 7, 2025 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced…

More Power, More Convenience, Less Hassle: Roborock Expands Entry-Range Lineup

Roborock expands the Q Series with the launch of the Q7T+, Q10V+…

Roborock Launches Qrevo Series in Australia and New Zealand, Bringing Premium Innovation to the Mid-Range Market

SYDNEY, May 7, 2025 /PRNewswire/ — Roborock, a global leader in ultra-intelligent…

Cronometer Offers Free Access to Women's Health Nutrition Score This May to Help Close Australia's Nutrient Gaps

Globally trusted nutrition tracker is making its evidence-based Women’s Health Nutrition Score…

XChange TEC.INC Announces Plan to Implement ADS Ratio Change

SHANGHAI, May 7, 2025 /PRNewswire/ — XChange TEC.INC (NASDAQ: XHG) (the "Company")…

Golden Heaven Group Holdings Ltd. Announces 25 for 1 Share Consolidation

NANPING, China, May 7, 2025 /PRNewswire/ — Golden Heaven Group Holdings Ltd.…

REALTY ONE GROUP OPENS IN BAJA AND PACIFIC MEXICO

The Region Becomes Part of the Popular, Fast-Growing Real Estate Brand’s 25…

FutureLink Boston 2025 Reinforces TraceLink's Leadership in Supply Chain Orchestration and Innovation

BOSTON, May 7, 2025 /PRNewswire/ — TraceLink, the largest end-to-end digital network…